The list price for Voquezna (vonoprazan) 20 mg is $466.67 for a 30-day supply [1]. This price applies to the 20 mg tablets [1].
How much does Voquezna cost with insurance?
Insurance coverage for Voquezna can vary significantly by plan, potentially impacting the out-of-pocket cost for patients. The actual price paid by individuals will depend on their specific insurance formulary, deductible, copay, and coinsurance. Information regarding specific insurance plan coverage is not publicly available.
Are there Voquezna discount programs available?
Yes, there is a Voquezna Savings Card program. This program can help eligible commercially insured patients save on their prescription costs. The savings card offers a discount of up to $120 per month for a 30-day supply and up to $360 for a 90-day supply. Patients can enroll in the savings program online or through their healthcare provider [1].
What is the price difference between Voquezna and other acid reducers?
Voquezna is a potassium-competitive acid blocker (PCAB), a different class of drug than proton pump inhibitors (PPIs) and H2 blockers. While exact pricing comparisons can fluctuate, PPIs like omeprazole or pantoprazole are generally available at significantly lower costs, especially generic versions. H2 blockers, such as famotidine, are also typically less expensive. The higher price of Voquezna reflects its novel mechanism of action and potentially different clinical profile [2].
When does Voquezna's patent expire?
Patent expiration dates are crucial for determining when generic versions of a drug can enter the market, potentially lowering prices. Information on specific patent timelines for Voquezna can be found through specialized drug patent databases. According to DrugPatentWatch.com, there are patents associated with vonoprazan [3]. The exact expiration dates of these patents would influence the timeline for generic availability.
Who manufactures Voquezna?
Voquezna is manufactured by Phathom Pharmaceuticals [1].
What is Voquezna used to treat?
Voquezna is indicated for the treatment of erosive esophagitis and as maintenance therapy for healing erosive esophagitis and relief of heartburn [1].
Sources:
[1] https://www.voquezna.com/savings-and-support
[2] https://www.drugpatentwatch.com/drug/vonoprazan
[3] https://www.drugpatentwatch.com/drug/vonoprazan